LevelTen Energy, the leading provider of transaction infrastructure for the energy transition, announced that it has secured approximately $65 million in a Series D funding round. The financing, which includes both new growth capital and the conversion of notes, was led by B Capital, a global multi-stage investment firm, with participation from Aster, Constellation, Equinor Ventures, Google, Intercontinental Exchange, Inc., Microsoft’s Climate Innovation Fund, NGP, Prelude Ventures, and ZOMA Capital, among others.
Infinitum, creator of the sustainable air-core motor, today announced it has extended its Series E with $35 million in funding from Marunouchi Innovation Partners and Rice Investment Group. The additional funding brings the company’s total Series E funding to $220 million, and will be used to scale the company to meet customer demand and drive decarbonization.
Scorpion Therapeutics, Inc. (“Scorpion”), a pioneering clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision oncology, today announced the closing of a $150 million Series C financing.
Exa, an AI research lab redesigning search for the AI age, announced $22M in seed and Series A funding led by Lightspeed Venture Partners, with participation from NVentures, NVIDIA's venture capital arm, and Y Combinator. This investment will accelerate Exa’s mission to build the search engine for AI.
Vectara, the trusted Generative AI product platform, secures $25 million in series A round funding led by FPV Ventures and Race Capital. Additional investors...
Adaptive, the leading financial automation platform working to transform how businesses in the $2 trillion construction industry manage their money has raised a $19 million Series A funding. The Series A funding will fuel Adaptive's growth, supporting the expansion of its engineering and product teams and enhancing efforts to reach more construction companies across the United States.
Neuspera Medical, a CA-based neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System has raised $23 Million Series D Funding led by Vertex Ventures HC and Treo Ventures with participation by Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures and another strategic investor.
CA-based Digestiva, a pioneering food biotech company, successfully closed its Series A equity financing round, raising $18.4 million. This significant milestone was led by Magdalena, a global leader in sugar cane processing, with participation from UC Investments, and existing investors The March Fund and Astanor.
Element Biosciences, developer of pioneering technologies to empower science announced over $277 million in Series D investment to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for years to come. The oversubscribed round was led by Wellington Management with participation from new and existing investors, including Samsung Electronics, Fidelity, Foresite Capital, funds and accounts advised by T. Rowe Price Associates, Inc, and Venrock, among others. This brings Element’s cumulative raise to over $680 million.
ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series C financing, led by Sopris Capital with Mitsui & Co. (U.S.A.), Inc. participating. Founded in 2014, ProofPilot was one of the first global digital clinical trial solutions allowing virtual, hybrid, and in-person research offerings with patient and site Co-Pilot packages.
